Search

Your search keyword '"R. Leyh"' showing total 15 results
Start Over Author "R. Leyh" Topic internal medicine
15 results on '"R. Leyh"'

4. Association of very low PSA with increased metastases and death in patients with biopsy Gleason score 8-10 prostate cancer

Author

D. Tilki, F. Preisser, P. Gild, M. Fisch, S-R. Leyh-Bannurah, Raisa S. Pompe, H. Huland, M. Graefen, and G. Salomon

Subjects
Oncology, medicine.medical_specialty, medicine.diagnostic_test, business.industry, Urology, medicine.disease, lcsh:Diseases of the genitourinary system. Urology, lcsh:RC870-923, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, Prostate cancer, Internal medicine, Biopsy, medicine, In patient, business
Published
2020

5. Single Carotid Cannulation for Selective Antegrade Cerebral Perfusion: A Safe and Effective Tailored Approach in Moderate-Risk Patients undergoing Contemporary Minimally Invasive Primary Aortic Arch Repair

Author

D. Radakovic, N. Madrahimov, A. Magyar, R. Leyh, J. Wendel, C. Bening, A. Gorski, V. Sales, K. Penov, and K. Alhussini

Subjects
Aortic arch, medicine.medical_specialty, Tailored approach, business.industry, Internal medicine, medicine.artery, medicine, Cardiology, Cerebral perfusion pressure, business
Published
2020
Full Text
View/download PDF

7. Impact of preoperative risk on metastatic progression and cancer specific death in patients with adverse pathology at radical prostatectomy

Author

Axel Haferkamp, S-R. Leyh-Bannurah, Lars Budäus, Derya Tilki, Katharina Boehm, Markus Graefen, and Clemens M. Rosenbaum

Subjects
Oncology, medicine.medical_specialty, business.industry, Prostatectomy, Urology, General surgery, medicine.medical_treatment, Preoperative risk, 030232 urology & nephrology, Cancer, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, In patient, business
Published
2017
Full Text
View/download PDF

8. Begrenzung und Abbruch lebenserhaltender Maßnahmen bei kritisch kranken kardiochirurgischen Patienten

Author

S.-P. Sommer, R. Leyh, Khaled Hamouda, Christoph Schimmer, Marcus Leistner, and M. Oezkur

Subjects
Withholding Treatment, Patient care team, business.industry, 030208 emergency & critical care medicine, Emergency Nursing, Critical Care and Intensive Care Medicine, medicine.disease, Life Support Care, 03 medical and health sciences, 0302 clinical medicine, 030228 respiratory system, Emergency Medicine, Internal Medicine, medicine, Interdisciplinary communication, Intersectoral Collaboration, Medical emergency, Presumed consent, business
Abstract

Hintergrund Ethische und medizinische Kriterien der Entscheidungsfindung bezuglich Therapiebegrenzung oder Therapieabbruch von lebenserhaltenden Masnahmen bei kritisch kranken Patienten stellen eine grose Herausforderung in der Intensivmedizin dar.

Published
2015
Full Text
View/download PDF

10. Survival benefit of local vs. no local treatment for metastatic prostate cancer - impact of baseline PSA and metastatic substages

Author

P.I. Karakiewicz, Derya Tilki, M. Graefen, L. Cindolo, Felix Preisser, H. Huland, S-R. Leyh-Bannurah, Michele Marchioni, H. Davis-Bondarenko, S.F. Shariat, Marco Bandini, G. Philipp, Raisa S. Pompe, Ariane Smith, N. Fossati, Z. Tian, and Alberto Briganti

Subjects
Oncology, medicine.medical_specialty, business.industry, Urology, 030232 urology & nephrology, medicine.disease, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Survival benefit, 030220 oncology & carcinogenesis, Internal medicine, medicine, Baseline (configuration management), business
Published
2018
Full Text
View/download PDF

11. Oncological and functional outcomes after RP for high or very high-risk prostate cancer – European validation of the current NCCN guideline

Author

H. Huland, M. Graefen, P.I. Karakiewicz, Georg Salomon, S-R. Leyh-Bannurah, Raisa S. Pompe, Philipp Gild, Derya Tilki, and Felix K.-H. Chun

Subjects
Gynecology, Oncology, medicine.medical_specialty, Prostate cancer, business.industry, Urology, Internal medicine, Medicine, Guideline, business, medicine.disease, Very high risk
Published
2017
Full Text
View/download PDF

12. 727 Inverse stage migration: Contemporary results of 140.253 North American prostate cancer patients treated with radical prostatectomy from 2004 to 2012

Author

Alberto Briganti, F. Montorsi, M. Graefen, Lars Budäus, M. Fisch, P.I. Karakiewicz, S-R. Leyh-Bannurah, and P. Dell’Oglio

Subjects
Oncology, medicine.medical_specialty, Prostate cancer, Prostatectomy, business.industry, Urology, Internal medicine, medicine.medical_treatment, medicine, medicine.disease, business, Stage migration
Published
2016
Full Text
View/download PDF

13. 359 Identification of apparent-diffusion-coefficient (ADC) cut-offs during DWI-MRI in prostate cancer lymph node metastasis: Implication for daily clinical practice

Author

Lars Budäus, C. Seiwerts, M. Regier, M. Graefen, Burkhard Beyer, Hans Heinzer, G Adam, S-R. Leyh-Bannurah, and Georg Salomon

Subjects
Oncology, Clinical Practice, medicine.medical_specialty, Prostate cancer, business.industry, Urology, Internal medicine, medicine, Effective diffusion coefficient, Lymph node metastasis, medicine.disease, business, Diffusion MRI
Published
2013
Full Text
View/download PDF

14. Does an aortopulmonary shunt before repair of tetralogy of Fallot limit exercise tolerance in long-term survivors?

Author

Böhle As, R. Leyh, Hans H. Sievers, and Alexander Bernhard

Subjects
Adult, Male, medicine.medical_specialty, Adolescent, Anaerobic Threshold, Working capacity, Doppler echocardiography, Pulmonary function testing, Postoperative Complications, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, Lung, Tetralogy of Fallot, medicine.diagnostic_test, business.industry, Palliative Care, Angiography, Hemodynamics, Exercise capacity, medicine.disease, Survival Rate, medicine.anatomical_structure, Echocardiography, Cardiology, Exercise Test, Pulmonary Diffusing Capacity, Surgery, Female, Cardiology and Cardiovascular Medicine, business, Anaerobic exercise, Shunt (electrical), Blood Flow Velocity, Follow-Up Studies
Abstract

The purpose of this study was to evaluate the impact of an aortopulmonary shunt on exercise capacity in long-term survivors after total repair of tetralogy of Fallot (17.6(2.0) years' follow-up). Submaximal exercise tests, pulmonary function tests, lung diffusion tests for carbon monoxide, two-dimensional and Doppler echocardiography were performed in 12 patients with an aortopulmonary shunt (group A) and in 21 patients (group B) without a shunt before repair. There were no significant differences in two-dimensional and Doppler echocardiographic findings nor in pulmonary function. Group A showed a significantly lower diffusion capacity of the lung for carbon monoxide at rest (66.2(13.0)% versus 84.1(9.5)%; P < 0.01) and at the anaerobic threshold (71.8(11.0)% versus 87.2(9.8)%; P < 0.01) as well as a significantly reduced physical working capacity at ventilatory anaerobic threshold (1.6) (0.32) W/kg versus 2.41(0.43) W/kg; p < 0.01). A negative correlation was observed between the duration of palliative shunts and diffusion capacity of the lung for carbon monoxide at rest at ventilatory anaerobic threshold (r = −0.8635 and −0.9108 respectively). A shunt placed before definitive repair impairs the long-term working capacity, probably by diminishing the diffusion capacity of the lung for carbon monoxide, especially if the shunt is in place for more than 20 months.

Published
1995

Catalog

Books, media, physical & digital resources
See catalog results